myBrain Technologies

Discover the team, the experts and scientists as well as the partners.

myBrain Technologies

Discover the team, the experts and scientists as well as the partners.

myBrain Technologies

Discover the team, the experts and scientists as well as the partners.

logo concours mondial innovation

MyBrain Technologies is one of 12 innovative companies qualified for the Global Innovation Competition – phase 3 – 2020 “, Individualized Medicine Category

Spin-off created at the brain institute (ICM) based at the Pitié-Salpêtrière hospital in Paris, myBrain Technologies is developing a brain data platform and technological solutions based on the latest advances in neuroscience and artificial intelligence.

The company’s objective is to analyze human brain activity on a large scale in order to identify and exploit neuro-markers linked to specific brain processes (stress, relaxation, focus, emotions, breathing, …) in the market of well-being and mental health.

Melomind is a scientifically validated stress assessment and brain training neurofeedback solution.

MyBrain Technologies has already commercialized its product, melomind, in the wellness sector. Its ease-of-use and the efficiency have already benefited 3,000 individual users, corresponding to more than 40,000 brain training sessions. 

MyBrain Technologies is now leveraging new assets to enter the medical sector with a complementary Medical Platform, which will provide significant data to healthcare professionals to assess and monitor patients progress regarding their anxiety and potentially depressive states.

In the expansion phase, the company is looking for new privileged partnerships in the medical field and pharmaceutical industries. 

myBrain Technologies

Discover the team, the experts and scientists as well as the partners.

Spin-off created at the brain institute based at the Pitié-Salpêtrière hospital in Paris, myBrain Technologies is developing a brain data platform and technological solutions based on the latest advances in neuroscience and artificial intelligence.

The company’s objective is to analyze human brain activity on a large scale in order to identify and exploit neuro-markers linked to specific brain processes (stress, relaxation, focus, emotions, breathing, …) in the market of well-being and mental health.

Melomind is a scientifically validated stress assessment and brain training neurofeedback solution.

MyBrain Technologies has already commercialized its product, melomind, in the wellness sector. Its ease-of-use and the efficiency have already benefited 3,000 individual users, corresponding to more than 40,000 brain training sessions. 

MyBrain Technologies is now leveraging new assets to enter the medical sector with a complementary Medical Platform, which will provide significant data to healthcare professionals to assess and monitor patients progress regarding their anxiety and potentially depressive states.

In the expansion phase, the company is looking for new privileged partnerships in the medical field and pharmaceutical industries. 

6

Years of R&D

9

Million € of fund raising

40 000

Brain Training 
Sessions

30

Collaborators

Our team

MyBrain Technologies has 30 people, a team that combines expertise in cognitive neuroscience, EEG-based device engineering and intelligent data analysis. This multidisciplinary approach makes it possible to offer a wide variety of solutions (monitoring, diagnosis, prevention, neurofeedback, etc.), through various applications (relaxation, emotion management, breathing).

YOHAN ATTAL
CEO ; Co-founder

  • 14 years of experience in Neuroscience Research and Entrepreneurship.
  • PhD from the University of Paris XI-Orsay (Brain Imaging) & the University of Nice Sophia-Antipolis University (Signal processing and automation)

JULIEN FISZMAN
Chief Business Officer ; Co-founder

  • 7 years experience in Business Development
  • MSc from the Sorbonne University (Innovation Management)
philippe_hartmanshenn-black-white

Philippe HARTMANSHENN
Chief Operating Officer

  • +30 years of expérience as CEO and COO in international groups for new technologies industry
  • Executive Master – ESSEC

Caroline ATLANI
Chief Medical Officer

  • 25 years of experience in Medical, Public Affairs and Operations
  • Pierre and Marie Curie University

Xavier NAVARRO
Head of signal processing

  • 11 years of experience in Neuroscience Research
  • PhD from the University of Rennes
  • Postdoc at the Brain and Spinal Cord Institute

Franck Bongard
Chief Technical Officer

  • 20 ans d’expérience en développement de plateformes Big Data
  • Autodidacte en Computer Science
sophie duffaure

Sophie DUFFAURE
Quality manager

  • 13 years of experience in Quality Management in innovation-oriented companies
giuseppe

GIUSEPPE SPINELLI
HEAD OF INNOVATION LAB

  • Ph.D from Sapienza University in Rome (Italy) and researcher at the Brain Institute (ICM) in Paris
  • 7 years of experience in Neuroscience Research and EEG signal processing

Our scientific board

The myBrain Technologies Scientific Board brings together leading experts and
scientists in the field of neuroscience, neurotechnology and health.

DR. NATHALIE GEORGE

  • Phd
  • Expert in Social and Emotional Neurosciences
  • Brain and Spinal Cord Institute (BCI)

PR. PHILIPPE FOSSATI

  • PhD, MD
  • Director of the Control – Interception – Attention team.
  • Professor of Psychiatry
  • Brain and Spinal Cord Institute (BCI) Pitié-Salpêtrière Hospital

PR. THOMAS SIMILOWSKI

  • PhD, MD
  • Director of the Pulmonology and Resuscitation Department
  • Director of Experimental and Clinical Respiratory Neurophysiology Pitié-Salpêtrière Hospital UPMC

DR. MARIO CHAVEZ

  • PhD
  • Expert in Brain Dynamics Analysis
  • Brain and Spinal Cord Institute (BCI)

PR. JEAN-MARIE GANASCIA

  • PhD
  • Professor of AI
  • Director of the Ethics Committee CNRS
  • Author of 10 books on AI and cognition
  • Lip6

PPR. SYLVAIN BAILLET

  • PhD
  • Head of Mc Connel Institute
  • Professor of Neurology and Neurosurgery
  • Former head of the Brain Imaging Lab – CNRS
    McGill University

DR. GUILLAUME DUMAS

  • PhD
  • Embodieed & Reciprocal Expert
  • Nature of human cognition
    Pasteur Institute

We are proud to collaborate with prestigious partners to contribute to innovation in

the field of neurotechnology and health.

Our scientific partnerships

They support us

They talk about Melomind